Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Armstrong, MJ, Gaunt, P, Aithal, GP et al. (14 more authors) (2016) Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. The Lancet, 387 (10019). pp. 679-690. ISSN 0140-6736

Abstract

Metadata

Authors/Creators:
  • Armstrong, MJ
  • Gaunt, P
  • Aithal, GP
  • Barton, D
  • Hull, D
  • Parker, R
  • Hazlehurst, JM
  • Guo, K
  • LEAN trial team
  • Abouda, G
  • Aldersley, MA
  • Stocken, D ORCID logo https://orcid.org/0000-0001-8031-1738
  • Gough, SC
  • Tomlinson, JW
  • Brown, RM
  • Hübscher, SG
  • Newsome, PN
Dates:
  • Published (online): 19 November 2015
  • Published: 13 February 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Aug 2020 11:15
Last Modified: 12 Apr 2021 10:57
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/s0140-6736(15)00803-x
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics